Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Sanofi/BMS antiplatelet agent introduced in U.K.

Sep. 17, 1998

Organon discovers new pharmacophore providing potent, orally active thrombin inhibitors

Sep. 17, 1998

Biovail subsidiary will market clot buster in Canada

Sep. 16, 1998

YM-75466 exerts antithrombotic effects at doses that do not alter bleeding and coagulation times

Sep. 16, 1998

Design and synthesis of cycloheptylurea factor Xa inhibitors reported by DuPont

Sep. 16, 1998

Organon designs novel acylguanidine-containing thrombin inhibitors

Sep. 16, 1998

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Sep. 16, 1998

Orally active anticoagulants in early development at Gedeon Richter

Sep. 14, 1998

Antiplatelet compounds developed by Merck & Co.

Sep. 14, 1998

Antithrombotic and antiplatelet actions of combination ticlopidine/EGb-761 therapy

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 26, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 26, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...